325 related articles for article (PubMed ID: 21833948)
1. Oral substitution treatment of injecting opioid users for prevention of HIV infection.
Gowing L; Farrell MF; Bornemann R; Sullivan LE; Ali R
Cochrane Database Syst Rev; 2011 Aug; (8):CD004145. PubMed ID: 21833948
[TBL] [Abstract][Full Text] [Related]
2. Substitution treatment of injecting opioid users for prevention of HIV infection.
Gowing L; Farrell M; Bornemann R; Sullivan L; Ali R
Cochrane Database Syst Rev; 2008 Apr; (2):CD004145. PubMed ID: 18425898
[TBL] [Abstract][Full Text] [Related]
3. Substitution treatment of injecting opioid users for prevention of HIV infection.
Gowing L; Farrell M; Bornemann R; Ali R
Cochrane Database Syst Rev; 2004 Oct; (4):CD004145. PubMed ID: 15495080
[TBL] [Abstract][Full Text] [Related]
4. Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.
Gowing LR; Farrell M; Bornemann R; Sullivan LE; Ali RL
J Gen Intern Med; 2006 Feb; 21(2):193-5. PubMed ID: 16336624
[TBL] [Abstract][Full Text] [Related]
5. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.
Barajas-Nava L
J Assoc Nurses AIDS Care; 2017; 28(5):832-833. PubMed ID: 28652132
[No Abstract] [Full Text] [Related]
6. Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.
Larney S
Addiction; 2010 Feb; 105(2):216-23. PubMed ID: 20078480
[TBL] [Abstract][Full Text] [Related]
7. Slow-release oral morphine as maintenance therapy for opioid dependence.
Ferri M; Minozzi S; Bo A; Amato L
Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
[TBL] [Abstract][Full Text] [Related]
8. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
Ng BE; Butler LM; Horvath T; Rutherford GW
Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
[TBL] [Abstract][Full Text] [Related]
9. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Sangani P; Rutherford G; Wilkinson D
Cochrane Database Syst Rev; 2004; (2):CD001220. PubMed ID: 15106156
[TBL] [Abstract][Full Text] [Related]
10. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
Lawrinson P; Ali R; Buavirat A; Chiamwongpaet S; Dvoryak S; Habrat B; Jie S; Mardiati R; Mokri A; Moskalewicz J; Newcombe D; Poznyak V; Subata E; Uchtenhagen A; Utami DS; Vial R; Zhao C
Addiction; 2008 Sep; 103(9):1484-92. PubMed ID: 18636999
[TBL] [Abstract][Full Text] [Related]
11. Methadone at tapered doses for the management of opioid withdrawal.
Amato L; Davoli M; Minozzi S; Ali R; Ferri M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003409. PubMed ID: 16034898
[TBL] [Abstract][Full Text] [Related]
12. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
[TBL] [Abstract][Full Text] [Related]
13. Population-based interventions for reducing sexually transmitted infections, including HIV infection.
Wilkinson D; Rutherford G
Cochrane Database Syst Rev; 2001; (2):CD001220. PubMed ID: 11405980
[TBL] [Abstract][Full Text] [Related]
14. Methadone at tapered doses for the management of opioid withdrawal.
Amato L; Davoli M; Minozzi S; Ferroni E; Ali R; Ferri M
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003409. PubMed ID: 23450540
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of opiate substitution treatment in reducing HIV risk behaviors among African, Caribbean, and Black people: a systematic review.
Nguemo Djiometio JB; Buzuayew A; Mohamud H; Njoroge I; Kahan M; Nelson LE
JBI Evid Synth; 2021 Aug; 19(8):1887-1914. PubMed ID: 33851941
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Mattick RP; Kimber J; Breen C; Davoli M
Cochrane Database Syst Rev; 2008 Apr; (2):CD002207. PubMed ID: 18425880
[TBL] [Abstract][Full Text] [Related]
17. Opioid treatment in Ukraine risks losing momentum.
Bull World Health Organ; 2013 Feb; 91(2):87-8. PubMed ID: 23554519
[TBL] [Abstract][Full Text] [Related]
18. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
19. Methadone maintenance therapy as evidence based drug abuse planning in developed countries: can developing countries afford and learn from this experience?
Nsimba SE
East Afr J Public Health; 2010 Mar; 7(1):54-7. PubMed ID: 21413573
[TBL] [Abstract][Full Text] [Related]
20. Injecting drug users and HIV/AIDS: risk behaviours and risk perception.
Crisp BR; Barber JG; Ross MW; Wodak A; Gold J; Miller ME
Drug Alcohol Depend; 1993 Jun; 33(1):73-80. PubMed ID: 8370340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
